Gallagher C, Ha D, Harvey R, Vandenberg R
Pharmacol Rev. 2023; 74(4):933-961.
PMID: 36779343
PMC: 9553105.
DOI: 10.1124/pharmrev.122.000583.
Ivica J, Zhu H, Lape R, Gouaux E, Sivilotti L
Elife. 2022; 11.
PMID: 35975975
PMC: 9462852.
DOI: 10.7554/eLife.79148.
Kumar A, Basak S, Rao S, Gicheru Y, Mayer M, Sansom M
Nat Commun. 2020; 11(1):3752.
PMID: 32719334
PMC: 7385131.
DOI: 10.1038/s41467-020-17364-5.
Pless S, Sivilotti L
Curr Opin Physiol. 2019; 2:19-26.
PMID: 31231710
PMC: 6588529.
DOI: 10.1016/j.cophys.2017.12.012.
Huang X, Shaffer P, Ayube S, Bregman H, Chen H, Lehto S
Nat Struct Mol Biol. 2016; 24(2):108-113.
PMID: 27991902
DOI: 10.1038/nsmb.3329.
Glycine receptor mechanism elucidated by electron cryo-microscopy.
Du J, Lu W, Wu S, Cheng Y, Gouaux E
Nature. 2015; 526(7572):224-9.
PMID: 26344198
PMC: 4659708.
DOI: 10.1038/nature14853.
Principles of agonist recognition in Cys-loop receptors.
Lynagh T, Pless S
Front Physiol. 2014; 5:160.
PMID: 24795655
PMC: 4006026.
DOI: 10.3389/fphys.2014.00160.
A cation-π interaction at a phenylalanine residue in the glycine receptor binding site is conserved for different agonists.
Pless S, Hanek A, Price K, Lynch J, Lester H, Dougherty D
Mol Pharmacol. 2011; 79(4):742-8.
PMID: 21266487
PMC: 3063724.
DOI: 10.1124/mol.110.069583.
Interaction of androsterone and progesterone with inhibitory ligand-gated ion channels: a patch clamp study.
Ziegler E, Bodusch M, Song Y, Jahn K, Wolfes H, Steinlechner S
Naunyn Schmiedebergs Arch Pharmacol. 2009; 380(4):277-91.
PMID: 19705103
DOI: 10.1007/s00210-009-0440-x.
Ligand-specific conformational changes in the alpha1 glycine receptor ligand-binding domain.
Pless S, Lynch J
J Biol Chem. 2009; 284(23):15847-56.
PMID: 19286654
PMC: 2708881.
DOI: 10.1074/jbc.M809343200.
A cation-pi interaction in the binding site of the glycine receptor is mediated by a phenylalanine residue.
Pless S, Millen K, Hanek A, Lynch J, Lester H, Lummis S
J Neurosci. 2008; 28(43):10937-42.
PMID: 18945901
PMC: 2649377.
DOI: 10.1523/JNEUROSCI.2540-08.2008.
5-HT3 receptors.
Thompson A, Lummis S
Curr Pharm Des. 2006; 12(28):3615-30.
PMID: 17073663
PMC: 2664614.
DOI: 10.2174/138161206778522029.
Charged residues in the alpha1 and beta2 pre-M1 regions involved in GABAA receptor activation.
Mercado J, Czajkowski C
J Neurosci. 2006; 26(7):2031-40.
PMID: 16481436
PMC: 6674915.
DOI: 10.1523/JNEUROSCI.4555-05.2006.
Differential agonist sensitivity of glycine receptor alpha2 subunit splice variants.
Miller P, Harvey R, Smart T
Br J Pharmacol. 2004; 143(1):19-26.
PMID: 15302677
PMC: 1575261.
DOI: 10.1038/sj.bjp.0705875.
Extrinsic factors regulate partial agonist efficacy of strychnine-sensitive glycine receptors.
Farroni J, McCool B
BMC Pharmacol. 2004; 4:16.
PMID: 15301692
PMC: 514606.
DOI: 10.1186/1471-2210-4-16.
Selective antagonism of rat inhibitory glycine receptor subunits.
Han Y, Li P, Slaughter M
J Physiol. 2003; 554(Pt 3):649-58.
PMID: 14645455
PMC: 1664810.
DOI: 10.1113/jphysiol.2003.056309.
Mechanisms of H+ modulation of glycinergic response in rat sacral dorsal commissural neurons.
Li Y, Wu L, Li Y, Xu L, Xu T
J Physiol. 2003; 552(Pt 1):73-87.
PMID: 12855675
PMC: 2343322.
DOI: 10.1113/jphysiol.2003.047324.
Kinetic determinants of agonist action at the recombinant human glycine receptor.
Lewis T, Schofield P, McClellan A
J Physiol. 2003; 549(Pt 2):361-74.
PMID: 12679369
PMC: 2342959.
DOI: 10.1113/jphysiol.2002.037796.
Prediction of 5-HT3 receptor agonist-binding residues using homology modeling.
Reeves D, Sayed M, Chau P, Price K, Lummis S
Biophys J. 2003; 84(4):2338-44.
PMID: 12668442
PMC: 1302800.
DOI: 10.1016/S0006-3495(03)75039-5.
Microscopic kinetics and energetics distinguish GABA(A) receptor agonists from antagonists.
Jones M, Jonas P, Sahara Y, Westbrook G
Biophys J. 2001; 81(5):2660-70.
PMID: 11606279
PMC: 1301733.
DOI: 10.1016/S0006-3495(01)75909-7.